Bernhard Wunsch
Muenster, NW 48149, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 232 publications
Diastereoselective synthesis of 1,4,8-trisubstituted perhydroquinolines as novel κ receptor agonists.
Journal: Organic & biomolecular chemistry
Published: May 22, 2026
Negative allosteric modulation of NMDA receptors with GluN2B subunit: synthesis of γ-amino alcohols embedded in a 1-benzoxepine scaffold.
Journal: RSC medicinal chemistry
Published: March 30, 2026
Electro-Mechanical Uncoupling of KV7.1 Voltage Sensor and Pore by 1,4-Benzodiazepines Is Modulated by Decoration of Position 1.
Journal: Archiv der Pharmazie
Published: March 11, 2026
Structure-Activity Relationship Study on Ligands Activating the Voltage-Gated Potassium Channel KV7.1.
Journal: Archiv der Pharmazie
Published: March 06, 2026
Forcing the phenyl moiety into the axial position by embedding the 2-phenyl-1,3-dioxane system in a tricyclic benzomorphan scaffold: design, synthesis and biological evaluation.
Journal: Organic & biomolecular chemistry
Published: February 23, 2026
Imaging of Fibroblast Activation Protein in the Microenvironment of Tumors by 18F‑Labeled Positron Emission Tomography Tracers with Increased Polarity.
Journal: ACS pharmacology & translational science
Published: January 23, 2026
Antiallodynic effect of a novel sigma-1 receptor antagonist N-(1-benzylpiperidin-4-yl)-2,4-dichlorobenzamide (Dicloperidine): Synthesis and combined bioevaluation.
Journal: Neuroscience letters
Published: January 13, 2026
Stereoselective Synthesis of Conformationally Restricted γ- and β-Amino Alcohols as GluN2B Subtype-Selective NMDA Receptor Antagonists.
Journal: Journal of medicinal chemistry
Published: December 30, 2025
Development of a MS binding assay to analyze the interactions of drugs with the ifenprodil binding site of NMDA receptors with GluN2B subunit.
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 03, 2025
Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure-Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments.
Journal: ACS infectious diseases
Published: August 11, 2025
Synthesis and Structure-Affinity Relationships of Receptor Ligands with 1,3-Dioxane Structure.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 28, 2025
Chiral pool synthesis of enantiomerically pure morphan derivatives with κ receptor affinity from (S)-perillaldehyde.
Journal: European journal of medicinal chemistry
Published: July 25, 2025
Last Updated: 09/26/2026